Fort Pitt Capital Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $159M | Buy |
256,315
+3,766
| +1% | +$2.33M | 4.46% | 2 |
|
|
2024
Q2 | $140M | Buy |
252,549
+5,357
| +2% | +$2.96M | 4.24% | 3 |
|
|
2024
Q1 | $144M | Buy |
247,192
+6,758
| +3% | +$3.93M | 4.43% | 2 |
|
|
2023
Q4 | $128M | Buy |
240,434
+59,941
| +33% | +$31.8M | 4.19% | 3 |
|
|
2023
Q3 | $91.4M | Buy |
180,493
+74,107
| +70% | +$37.5M | 3.43% | 6 |
|
|
2023
Q2 | $55.5M | Buy |
106,386
+3,805
| +4% | +$1.99M | 2.04% | 25 |
|
|
2023
Q1 | $59.1M | Buy |
102,581
+1,458
| +1% | +$840K | 2.28% | 18 |
|
|
2022
Q4 | $55.7M | Buy |
101,123
+2,736
| +3% | +$1.51M | 2.27% | 20 |
|
|
2022
Q3 | $49.9M | Buy |
98,387
+242
| +0.2% | +$123K | 2.29% | 21 |
|
|
2022
Q2 | $53.3M | Buy |
98,145
+3,826
| +4% | +$2.08M | 2.32% | 20 |
|
|
2022
Q1 | $55.7M | Buy |
94,319
+15,290
| +19% | +$9.03M | 2.08% | 21 |
|
|
2021
Q4 | $52.7M | Buy |
79,029
+4,525
| +6% | +$3.02M | 1.91% | 23 |
|
|
2021
Q3 | $42.6M | Buy |
74,504
+27,340
| +58% | +$15.6M | 1.77% | 27 |
|
|
2021
Q2 | $23.8M | Buy |
47,164
+5,618
| +14% | +$2.83M | 0.97% | 39 |
|
|
2021
Q1 | $19M | Buy |
41,546
+6,777
| +19% | +$3.09M | 0.85% | 43 |
|
|
2020
Q4 | $16.2M | Buy |
34,769
+2,233
| +7% | +$1.04M | 0.78% | 41 |
|
|
2020
Q3 | $14.4M | Buy |
32,536
+1,323
| +4% | +$584K | 0.8% | 39 |
|
|
2020
Q2 | $11.3M | Buy |
31,213
+911
| +3% | +$330K | 0.67% | 43 |
|
|
2020
Q1 | $8.59M | Buy |
30,302
+17,423
| +135% | +$4.94M | 0.59% | 46 |
|
|
2019
Q4 | $4.08M | Sell |
12,879
-149
| -1% | -$47.2K | 0.23% | 62 |
|
|
2019
Q3 | $3.8M | Buy |
+13,028
| New | +$3.8M | 0.23% | 63 |
|